Skip to main content
Premium Trial:

Request an Annual Quote

Japan Vaccine Approval Expected

A panel in Japan has given the OK for the emergency use of the Pfizer-BioNTech SARS-CoV-2 vaccine, Bloomberg reports.

It adds that this greenlight from the Ministry of Health's advisory Pharmaceutical Affairs and Food Sanitation Council could enable the vaccine to be approved as early as Sunday. If that happens, Bloomberg notes this would be Japan's first SARS-CoV-2 vaccine approval.

Prime Minister Yoshihide Suga has said, according to Bloomberg, that vaccinations would begin the middle of next week. Japan has a deal with Pfizer-BioNTech for 144 million vaccine doses, as well as agreements with AstraZeneca and the University of Oxford for their vaccine and Moderna for its vaccine, it adds. 

The Japan Times reports that the vaccine will first be given to 20,000 healthcare workers who will be monitored, then to additional healthcare workers in March and people over the age of 65 in April. According to NPR, Japan plans to have vaccinated most of its population by July, when the Tokyo Olympics are scheduled to begin. NPR says, though, that Japan's vaccination effort may be stymied by a shortage of the type of syringe that's needed to get six doses out of each vial, rather than five.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.